Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Population-based, Multicenter Cohort Study of Combined Screening for Gastrointestinal Tumors
Sponsor: Xijing Hospital
Summary
To establish combined gastroenteroscopy screening and follow-up management for gastrointestinal tumors, explore and evaluate the feasibility and health economic benefits of combined screening for esophagus, stomach and colorectal cancer
Key Details
Gender
All
Age Range
45 Years - 70 Years
Study Type
OBSERVATIONAL
Enrollment
84000
Start Date
2023-08-01
Completion Date
2033-06-30
Last Updated
2023-10-11
Healthy Volunteers
Yes
Conditions
Interventions
Gastroenteroscopy;Risk factor investigation; FIT-HP;RNF180 and SEPTIN9 gene methylation test
group one: The screening population will undergo gastroscopy, colonoscopy, fecal occult blood test (FIT), Helicobacter pylori (HP) antigen test, RNF180/Septin9 gene methylation test, and investigation of risk factors, including past disease history, alcohol drinking history, smoking history, tea drinking history, family history of cancer, marital and reproductive status, and dietary habits.
Risk factor investigation;
Only the risk factors will be investigated, including previous disease history, drinking history, smoking history, drinking history, family history of malignant tumor, marriage and childbearing status, eating habits, etc.
Gastroenteroscopy;Risk factor investigation; FIT-HP;RNF180 and SEPTIN9 gene methylation test
group two: The screening population will undergo investigation of risk factors, a fecal occult blood test (FIT), and a stool test for Helicobacter pylori (HP) antigen. If a stool occult blood test or H. pylori antigen is positive after testing, RNF180 and SEPTIN9 gene methylation testing will be scheduled. If the gene methylation test is positive, a colonoscopy will be scheduled.
Locations (1)
Gaoyao District People's Hospital
Zhaoqing, Guangzhou, China